1. Home
  2. OII vs DNLI Comparison

OII vs DNLI Comparison

Compare OII & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oceaneering International Inc.

OII

Oceaneering International Inc.

HOLD

Current Price

$52.73

Market Cap

4.1B

Sector

Energy

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$23.11

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OII
DNLI
Founded
1964
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
OII
DNLI
Price
$52.73
$23.11
Analyst Decision
Hold
Strong Buy
Analyst Count
3
14
Target Price
$31.33
$34.33
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
142.36
N/A
EPS
1.00
N/A
Revenue
$2,784,156,000.00
N/A
Revenue This Year
$2.83
N/A
Revenue Next Year
$5.34
$408.85
P/E Ratio
$133.39
N/A
Revenue Growth
4.62
N/A
52 Week Low
$20.79
$12.58
52 Week High
$51.48
$27.30

Technical Indicators

Market Signals
Indicator
OII
DNLI
Relative Strength Index (RSI) 82.37 45.21
Support Level $34.66 $18.27
Resistance Level N/A $23.27
Average True Range (ATR) 1.89 1.38
MACD 0.85 -0.39
Stochastic Oscillator 98.57 17.58

Price Performance

Historical Comparison
OII
DNLI

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: